166 related articles for article (PubMed ID: 38367748)
21. The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML).
Korbecki J; Kupnicka P; Barczak K; Bosiacki M; Ziętek P; Chlubek D; Baranowska-Bosiacka I
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760523
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
[TBL] [Abstract][Full Text] [Related]
23. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
Cieślak M; Roszek K; Wujak M
Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
[TBL] [Abstract][Full Text] [Related]
24. Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results.
Paudel YN; Angelopoulou E; Piperi C; Othman I; Shaikh MF
Pharmacol Res; 2020 Jun; 156():104792. PubMed ID: 32278047
[TBL] [Abstract][Full Text] [Related]
25. Looking to the Future of the Role of Macrophages and Extracellular Vesicles in Neuroinflammation in ALS.
Carata E; Muci M; Di Giulio S; Mariano S; Panzarini E
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511010
[TBL] [Abstract][Full Text] [Related]
26. The importance of CXC-receptors CXCR1-2 and CXCR4 for adaptive regulation of the stress axis in teleost fish.
Klak K; Maciuszek M; Marcinkowska M; Verburg-van Kemenade BML; Chadzinska M
Fish Shellfish Immunol; 2022 Aug; 127():647-658. PubMed ID: 35803509
[TBL] [Abstract][Full Text] [Related]
27. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
[TBL] [Abstract][Full Text] [Related]
28. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
29. Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).
Haidet-Phillips AM; Maragakis NJ
Brain Res; 2015 Dec; 1628(Pt B):343-350. PubMed ID: 26187754
[TBL] [Abstract][Full Text] [Related]
30. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
Sun X; Chen Q; Zhang L; Chen J; Zhang X
Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
[TBL] [Abstract][Full Text] [Related]
31. Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage.
Cristino S; Piacentini A; Manferdini C; Codeluppi K; Grassi F; Facchini A; Lisignoli G
Tissue Eng Part A; 2008 Jan; 14(1):97-105. PubMed ID: 18333808
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions.
Shandilya A; Mehan S
Neurol Sci; 2021 Aug; 42(8):3145-3166. PubMed ID: 34018075
[TBL] [Abstract][Full Text] [Related]
33. Targeting Extracellular Cyclophilin A Reduces Neuroinflammation and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pasetto L; Pozzi S; Castelnovo M; Basso M; Estevez AG; Fumagalli S; De Simoni MG; Castellaneta V; Bigini P; Restelli E; Chiesa R; Trojsi F; Monsurrò MR; Callea L; Malešević M; Fischer G; Freschi M; Tortarolo M; Bendotti C; Bonetto V
J Neurosci; 2017 Feb; 37(6):1413-1427. PubMed ID: 28011744
[TBL] [Abstract][Full Text] [Related]
34. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells.
Salcedo R; Resau JH; Halverson D; Hudson EA; Dambach M; Powell D; Wasserman K; Oppenheim JJ
FASEB J; 2000 Oct; 14(13):2055-64. PubMed ID: 11023990
[TBL] [Abstract][Full Text] [Related]
35. Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis.
Clark CM; Clark RM; Hoyle JA; Dickson TC
J Neurochem; 2021 Feb; 156(3):273-289. PubMed ID: 32654149
[TBL] [Abstract][Full Text] [Related]
36. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis.
Chiot A; Lobsiger CS; Boillée S
Curr Opin Neurol; 2019 Oct; 32(5):764-770. PubMed ID: 31306211
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
38. The Peripheral Immune System and Amyotrophic Lateral Sclerosis.
McCombe PA; Lee JD; Woodruff TM; Henderson RD
Front Neurol; 2020; 11():279. PubMed ID: 32373052
[TBL] [Abstract][Full Text] [Related]
39. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis.
Hooten KG; Beers DR; Zhao W; Appel SH
Neurotherapeutics; 2015 Apr; 12(2):364-75. PubMed ID: 25567201
[TBL] [Abstract][Full Text] [Related]
40. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
Wu C; Ma C; Yuan J; Zhou P
Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
